BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27286977)

  • 1. Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status.
    Shang J; Reece JC; Buchanan DD; Giles GG; Figueiredo JC; Casey G; Gallinger S; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    Int J Colorectal Dis; 2016 Aug; 31(8):1451-7. PubMed ID: 27286977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of developing a mismatch repair deficient colorectal cancer after undergoing cholecystectomy.
    Halldorsson MO; Hauptmann M; Snaebjornsson P; Haraldsdóttir KH; Aspelund T; Gudmundsson EF; Gudnason V; Jonasson JG; Haraldsdottir S
    Scand J Gastroenterol; 2018 Aug; 53(8):972-975. PubMed ID: 30010450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meat intake, cooking methods, dietary carcinogens, and colorectal cancer risk: findings from the Colorectal Cancer Family Registry.
    Joshi AD; Kim A; Lewinger JP; Ulrich CM; Potter JD; Cotterchio M; Le Marchand L; Stern MC
    Cancer Med; 2015 Jun; 4(6):936-52. PubMed ID: 25846122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.
    Win AK; Buchanan DD; Rosty C; MacInnis RJ; Dowty JG; Dite GS; Giles GG; Southey MC; Young JP; Clendenning M; Walsh MD; Walters RJ; Boussioutas A; Smyrk TC; Thibodeau SN; Baron JA; Potter JD; Newcomb PA; Le Marchand L; Haile RW; Gallinger S; Lindor NM; Hopper JL; Ahnen DJ; Jenkins MA
    Gut; 2015 Jan; 64(1):101-10. PubMed ID: 24615377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between family history and mismatch repair in colorectal cancer.
    Coggins RP; Cawkwell L; Bell SM; Crockford GP; Quirke P; Finan PJ; Bishop DT
    Gut; 2005 May; 54(5):636-42. PubMed ID: 15831908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
    Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
    Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
    Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
    J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases.
    Buchanan DD; Win AK; Walsh MD; Walters RJ; Clendenning M; Nagler B; Pearson SA; Macrae FA; Parry S; Arnold J; Winship I; Giles GG; Lindor NM; Potter JD; Hopper JL; Rosty C; Young JP; Jenkins MA
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):917-26. PubMed ID: 23462926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right-sided and left-sided colorectal cancer.
    Kanno H; Miyoshi H; Yoshida N; Sudo T; Nakashima K; Takeuchi M; Nomura Y; Seto M; Hisaka T; Tanaka H; Okuda K; Akagi Y; Ohshima K
    Cancer Sci; 2020 Aug; 111(8):3032-3044. PubMed ID: 32449240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
    Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
    In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.
    Chau R; Dashti SG; Ait Ouakrim D; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Macrae FA; Boussioutas A; Parry S; Figueiredo JC; Levine AJ; Ahnen DJ; Casey G; Haile RW; Gallinger S; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    Int J Epidemiol; 2016 Jun; 45(3):940-53. PubMed ID: 27063605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.
    Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS
    Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.
    Shaikh T; Handorf EA; Meyer JE; Hall MJ; Esnaola NF
    JAMA Oncol; 2018 Feb; 4(2):e173580. PubMed ID: 29121143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair status and synchronous metastases in colorectal cancer: A nationwide cohort study.
    Nordholm-Carstensen A; Krarup PM; Morton D; Harling H;
    Int J Cancer; 2015 Nov; 137(9):2139-48. PubMed ID: 25921209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?
    Bharati R; Jenkins MA; Lindor NM; Le Marchand L; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Win AK
    Gynecol Oncol; 2014 May; 133(2):287-92. PubMed ID: 24631449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
    Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
    J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative contrast-enhanced CT imaging and clinicopathological characteristics analysis of mismatch repair-deficient colorectal cancer.
    Chen S; Du W; Cao Y; Kong J; Wang X; Wang Y; Lu Y; Li X
    Cancer Imaging; 2023 Oct; 23(1):97. PubMed ID: 37828626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
    Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY
    World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.